Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference13 articles.
1. EMA (2012) Guideline on the investigation of drug interactions.https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-drug-interactions-revision-1_en.pdf
2. FDA (2020) In vitro drug interaction studies —cytochrome P450 enzyme- and transporter-mediated drug interactions guidance for industry. https://www.fda.gov/media/134582/download
3. Fowler S, Morcos PN, Cleary Y, Martin-Facklam M, Parrot N, Gertz M, Yu L (2017) Progress in prediction and interpretation of clinically relevant metabolic drug–drug interactions: a minireview illustrating recent developments and current opportunities. Curr Pharmacol Rep 3:36–49
4. Grizzle AJ, Horn J, Collins C, Schneider J, Malone DC, Stottlemyer B, Boyce RD (2019) Identifying common methods used by drug interaction experts for finding evidence about potential drug–drug interactions: web-based survey. J Med Internet Res 21:e11182
5. Pelkonen O, Mäenpää J, Taavitsainen P, Rautio A, Raunio H (1998) Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:1203–1253
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献